Yaming Zhang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Kaiqi Long, Wen Lv, Zihan Wang, Yaming Zhang, Kang Chen, Ni Fan, Feiyang Li, Yichi Zhang, Weiping Wang
Near-infrared light-triggered prodrug photolysis by one-step energy transfer. Nature communications 14 (1) (2023)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Kang Chen, Lai Yee Cheong, Yuan Gao, Yaming Zhang, Tianshi Feng, Qin Wang, Leigang Jin, Eric Honoré, Karen Siu-Ling Lam, Weiping Wang, Hannah Xiaoyan Hui, Aimin Xu
Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects. Nature communications 13 (1) (2022)
Yafei Li, Yang Zhou, Tianyi Wang, Kaiqi Long, Yaming Zhang, Weiping Wang
Photoenhanced cytosolic protein delivery based on a photocleavable group-modified dendrimer. Nanoscale 13 (42) (2021)